Heart Failure Reviews

Papers
(The median citation count of Heart Failure Reviews is 8. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-10-01 to 2024-10-01.)
ArticleCitations
Biomarkers for the diagnosis and management of heart failure174
COVID-19 and myocarditis: a systematic review and overview of current challenges125
Polypharmacy definition and prevalence in heart failure: a systematic review52
Dilated cardiomyopathy in the era of precision medicine: latest concepts and developments51
SGLT2-inhibitors; more than just glycosuria and diuresis51
Mechanisms of COVID-19-induced heart failure: a short review50
Oxidative stress and inflammation: determinants of anthracycline cardiotoxicity and possible therapeutic targets48
Screening for ATTR amyloidosis in the clinic: overlapping disorders, misdiagnosis, and multiorgan awareness40
Mitochondrial abnormalities: a hub in metabolic syndrome-related cardiac dysfunction caused by oxidative stress36
Resistance training in heart failure patients: a systematic review and meta-analysis32
Detection of myocardial fibrosis by speckle-tracking echocardiography: from prediction to clinical applications32
Immunity and inflammation: the neglected key players in congenital heart disease?31
Multiple roles of cardiac macrophages in heart homeostasis and failure31
Cardiogenic shock and acute kidney injury: the rule rather than the exception30
Current and emerging drug targets in heart failure treatment30
Ventricular non-compaction review29
A meta-analysis of microRNA expression profiling studies in heart failure27
Osteoprotegerin and RANKL-RANK-OPG-TRAIL signalling axis in heart failure and other cardiovascular diseases27
The non-invasive assessment of myocardial work by pressure-strain analysis: clinical applications27
Left ventricular hypertrophy and sudden cardiac death25
Heart failure and atrial fibrillation: new concepts in pathophysiology, management, and future directions24
Barth syndrome cardiomyopathy: targeting the mitochondria with elamipretide24
SGLT2 inhibitors break the vicious circle between heart failure and insulin resistance: targeting energy metabolism24
Cardiorenal syndrome: long road between kidney and heart23
Machine learning and statistical methods for predicting mortality in heart failure23
Therapeutic augmentation of NO-sGC-cGMP signalling: lessons learned from pulmonary arterial hypertension and heart failure23
Filamin C in cardiomyopathy: from physiological roles to DNA variants23
Mechanisms underlying the pathophysiology of heart failure with preserved ejection fraction: the tip of the iceberg23
Pirfenidone as a novel cardiac protective treatment22
Sodium glucose cotransporter 2 inhibitors: mechanisms of action in heart failure21
Prognostic value of natriuretic peptides in heart failure: systematic review and meta-analysis21
Myocarditis following COVID-19 vaccination in adolescents and adults: a cumulative experience of 202121
The use of diflunisal for transthyretin cardiac amyloidosis: a review21
The heart and gut relationship: a systematic review of the evaluation of the microbiome and trimethylamine-N-oxide (TMAO) in heart failure20
Heart–lung interactions in COVID-19: prognostic impact and usefulness of bedside echocardiography for monitoring of the right ventricle involvement19
Device-based treatment options for heart failure with preserved ejection fraction19
SGLT2 inhibitors: a focus on cardiac benefits and potential mechanisms19
SGLT2 inhibitors and cardiovascular and renal outcomes: a meta-analysis and trial sequential analysis19
Creatine deficiency and heart failure19
The protective effects of 17-β estradiol and SIRT1 against cardiac hypertrophy: a review19
Peripartum cardiomyopathy: a review18
Epidemiology and clinical manifestations of cardiac amyloidosis18
Practical recommendations for the diagnosis and management of transthyretin cardiac amyloidosis17
Lung ultrasound–guided management to reduce hospitalization in chronic heart failure: a systematic review and meta-analysis17
Left atrial structure and function in heart failure with reduced (HFrEF) versus preserved ejection fraction (HFpEF): systematic review and meta-analysis17
Management of RAASi-associated hyperkalemia in patients with cardiovascular disease17
The role of cardiac magnetic resonance imaging in the detection and monitoring of cardiotoxicity in patients with breast cancer after treatment: a comprehensive review17
Remote monitoring for heart failure using implantable devices: a systematic review, meta-analysis, and meta-regression of randomized controlled trials16
Hospitalisation costs associated with heart failure with preserved ejection fraction (HFpEF): a systematic review16
Factors associated with non-use and sub-target dosing of medical therapy for heart failure with reduced ejection fraction16
Balloon pulmonary angioplasty vs. pulmonary endarterectomy in patients with chronic thromboembolic pulmonary hypertension: a systematic review and meta-analysis16
Efficacy of motivational interviewing on enhancing self-care behaviors among patients with chronic heart failure: a systematic review and meta-analysis of randomized controlled trials15
New antidiabetic therapy and HFpEF: light at the end of tunnel?15
Beneficial effects on kidney during treatment with sodium-glucose cotransporter 2 inhibitors: proposed role of ketone utilization14
Psychological stress in heart failure: a potentially actionable disease modifier13
Effects of bromocriptine in peripartum cardiomyopathy: a systematic review and meta-analysis13
Dilated cardiomyopathy: a new insight into the rare but common cause of heart failure13
Amyloid seeding as a disease mechanism and treatment target in transthyretin cardiac amyloidosis13
The place of vericiguat in the landscape of treatment for heart failure with reduced ejection fraction12
The genetics of cardiac amyloidosis12
Targeting mitochondrial dysfunction with elamipretide12
Fibrosis in hypertrophic cardiomyopathy: role of novel echo techniques and multi-modality imaging assessment12
Elamipretide for Barth syndrome cardiomyopathy: gradual rebuilding of a failed power grid12
A systematic review exploring the significance of measuring epicardial fat thickness in correlation to B-type natriuretic peptide levels as prognostic and diagnostic markers in patients with or at ris12
A critical approach for successful use of circulating microRNAs as biomarkers in cardiovascular diseases: the case of hypertrophic cardiomyopathy11
The role of lymphangiogenesis in cardiovascular diseases and heart transplantation11
Prognostic impact of antiplatelet therapy in Takotsubo syndrome: a systematic review and meta-analysis of the literature11
Ultrafiltration is better than diuretic therapy for volume-overloaded acute heart failure patients: a meta-analysis11
The therapeutic effects of upgrade to cardiac resynchronization therapy in pacing-induced cardiomyopathy or chronic right ventricular pacing patients: a meta-analysis11
Cognitive impairment in heart failure: clinical implications, tools of assessment, and therapeutic considerations11
Vitamin C: historical perspectives and heart failure11
Cardiotoxicity in HER2-positive breast cancer patients11
The soluble catalytic ectodomain of ACE2 a biomarker of cardiac remodelling: new insights for heart failure and COVID1911
Complications in children with ventricular assist devices: systematic review and meta-analyses11
Speckle tracking echocardiography in primary mitral regurgitation: should we reconsider the time for intervention?11
MicroRNAs in hypertrophic cardiomyopathy: pathogenesis, diagnosis, treatment potential and roles as clinical biomarkers10
Soluble ST2: a valuable prognostic marker in heart failure10
The cardiosplenic axis: the prognostic role of the spleen in heart failure10
Serum potassium and heart failure: association, causation, and clinical implications10
Speckle tracking echocardiography in heart failure development and progression in patients with apneas10
Evaluation of donor heart for transplantation10
Subclinical cardiac damage in cancer patients before chemotherapy10
Intermittent levosimendan infusion in ambulatory patients with end-stage heart failure: a systematic review and meta-analysis of 984 patients9
Follistatin-like 1 and its paralogs in heart development and cardiovascular disease9
Treatment of cardiac fibrosis: from neuro-hormonal inhibitors to CAR-T cell therapy9
Clinical comparison of V122I genotypic variant of transthyretin amyloid cardiomyopathy with wild-type and other hereditary variants: a systematic review9
State-of-the art review: Noncompaction cardiomyopathy in pediatric patients9
Etiology and pathophysiology of heart failure in people with HIV9
Obesity, inflammation, and heart failure: links and misconceptions9
Is heart failure with preserved ejection fraction a ‘dementia’ of the heart?9
Cardiac resynchronization therapy in heart failure patients: tough road but clear future9
Assessment of acute heart failure prognosis: the promising role of prognostic models and biomarkers9
Echocardiographic assessment of cardiac amyloidosis8
Patients with fulminant myocarditis supported with veno-arterial extracorporeal membrane oxygenation: a systematic review and meta-analysis of short-term mortality and impact of risk factors8
ST-elevation myocardial infarction among cardiac amyloidosis patients; a national readmission database study8
Clinical variants of myocardial involvement in COVID-19-positive patients: a cumulative experience of 20208
Weighing in on heart failure: the potential impact of bariatric surgery8
The spectrum of lupus myocarditis: from asymptomatic forms to cardiogenic shock8
Challenge of post-COVID era: management of cardiovascular complications in asymptomatic carriers of SARS-CoV-28
Paradigm shift in heart failure treatment: are cardiologists ready to use gliflozins?8
The right ventricular involvement in dilated cardiomyopathy: prevalence and prognostic implications of the often-neglected child8
Large animal models of heart failure with preserved ejection fraction8
Impact of atrial fibrillation on the outcomes of transcatheter mitral valve repair using MitraClip: a systematic review and meta-analysis8
Left atrial assist device for heart failure with preserved ejection fraction: initial results with torque control mode in diastolic heart failure model8
Global longitudinal strain predicts responders after cardiac resynchronization therapy—a systematic review and meta-analysis8
Echocardiography for left ventricular assist device implantation and evaluation: an indispensable tool8
Advanced airway management and respiratory care in decompensated pulmonary hypertension8
Alterations of sodium-hydrogen exchanger 1 function in response to SGLT2 inhibitors: what is the evidence?8
0.088219881057739